Contracts › FA864925P0352
FA864925P0352: A Surge Capable, Non-Biologic (Animal and Human-Derived Tissue Free) Amino Acid Based Wound-Healing Matrix for Rapid Trauma Care and Streamlined Military Logistics.
Awarded to Matregenix Inc by Department of the Air Force.
$1.2Mobligated
$1.2Mpotential value
18 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | FA864925P0352 |
|---|---|
| Awardee | Matregenix Inc |
| Awarding agency | Department of the Air Force |
| Awarding office | FA8649 USAF SBIR STTR CNTRCTNG AFRL |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AC32 National Defense R&D Services; Defense-Related Activities; Applied Research |
| Place of performance | CA |
| Offers received | 115 |
| Period of performance | 18 July 2025 to 18 April 2027 |
| Potential end | 18 April 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record